CLINICAL MANIFESTATIONS Part of “CHAPTER 58 – PRIMARY HYPERPARATHYROIDISM“ The signs and symptoms of primary hyperparathyroidism result from the hypercalcemia (see Chap. 59) and the hyperparathyroid state. In primary hyperparathyroidism,…
PATHOPHYSIOLOGY Part of “CHAPTER 58 – PRIMARY HYPERPARATHYROIDISM“ The functional abnormality of primary hyperparathyroidism is incompletely understood. Normally, PTH secretion is tightly regulated by the serum ionized calcium concentration; it…
PRODUCTION AND METABOLISM OF VITAMIN D Part of “CHAPTER 54 – VITAMIN D“ PHOTOPRODUCTION Technically, vitamin D3 is not a true vitamin because it can be produced in the body….
PRIMARY HYPERPARATHYROIDISM Shonni J. Silverberg John P. Bilezikian Primary hyperparathyroidism is caused by excessive, abnormally regulated secretion of parathyroid hormone (PTH) from the parathyroid glands. Chronic exposure of its two…
CONCLUSIONS Part of “CHAPTER 57 – CLINICAL APPLICATION OF BONE MINERAL DENSITY MEASUREMENTS“ Related posts: RADIATION AND THYROID CARCINOMA PHYSICAL EXAMINATION AND MENSURATION HYPERTHYROIDISM IN THE CHILD HORMONE SECRETION CLINICAL…
WHY ARE BONE MASS MEASUREMENTS PERFORMED? Part of “CHAPTER 57 – CLINICAL APPLICATION OF BONE MINERAL DENSITY MEASUREMENTS“ There are three clinical applications for bone mass measurement. Each has a…
DIAGNOSIS OF OSTEOPOROSIS USING BONE DENSITOMETRY: THE WORLD HEALTH ORGANIZATION CRITERIA Part of “CHAPTER 57 – CLINICAL APPLICATION OF BONE MINERAL DENSITY MEASUREMENTS“ To allow bone densitometry to be used…
CLINICAL APPLICATION OF BONE MINERAL DENSITY MEASUREMENTS Paul D. Miller Abby Erickson Carol Zapalowski Bone densitometry is accepted as a useful quantitative measurement for assessing skeletal status and predicting the…
